background
acut
respiratori
distress
syndrom
ard
one
lethal
diseas
encount
pediatr
intens
care
unit
picu
etiolog
pathogen
prognost
factor
sever
ard
pulmonari
origin
children
respiratori
viru
infect
prospect
investig
method
enrol
children
fulfil
follow
criteria
picu
admiss
age
month
year
diagnosi
infecti
pneumonia
respiratori
viru
infect
develop
sever
ard
within
h
picu
admiss
pathogen
detect
blood
tracheal
lavag
fluid
use
molecular
techniqu
convent
cultur
system
serum
level
inflammatori
mediat
day
picu
admiss
examin
result
fiftyseven
patient
boy
median
age
month
enrol
multipl
viru
infect
coinfect
bacteriafungu
bacteremiafungemia
observ
children
respect
adenovirusb
measl
viru
cytomegaloviru
detect
predominantli
tracheal
lavag
fluid
statist
signific
differ
nonsurvivor
survivor
regard
type
pathogen
incid
multipl
viru
infect
gender
age
clinic
featur
treatment
serum
level
interferon
ifn
il
ratio
higher
nonsurvivor
conclus
upregul
detect
day
picu
admiss
found
one
possibl
prognost
factor
affect
fatal
outcom
result
suggest
modul
inflammatori
respons
critic
clinic
manag
children
ard
acut
respiratori
distress
syndrom
ard
clinic
biolog
heterogen
syndrom
sever
lung
inflamm
disord
present
rapidli
progress
hypoxemia
dyspnea
ard
princip
associ
direct
injuri
lung
infecti
pneumonia
indirect
injuri
lung
result
system
inflamm
nonpulmonari
sepsi
trauma
surgeri
pneumonia
remain
predomin
caus
death
children
year
age
common
trigger
ard
children
pediatr
ard
one
lethal
diseas
pediatr
intens
care
unit
picu
associ
high
rate
mortal
histor
pediatr
ard
defin
use
adult
ard
criteria
base
americaneuropean
consensu
confer
berlin
definit
pediatr
acut
lung
injuri
consensu
confer
publish
pediatricspecif
definit
ard
accord
berlin
definit
sever
ard
defin
hypoxemia
mm
hg
arteri
partial
pressur
oxygen
pao
mm
hg
fraction
inspir
oxygen
fio
ratio
pf
ratio
posit
endexpiratori
pressur
peep
previous
report
children
avian
influenza
viru
infect
develop
sever
ard
show
directli
infect
injur
alveolar
epitheli
cell
correl
express
level
cytokin
chemokinemrna
lung
tissu
patholog
molecular
biolog
examin
postmortem
biopsi
infect
lung
tissu
emerg
virus
avian
influenza
viru
sever
acut
respiratori
syndrom
corona
viru
sarscov
sever
inflammatori
mediat
report
biomark
ard
potenti
predictor
poor
outcom
howev
studi
examin
inflammatori
respons
specif
sever
ard
pulmonari
origin
children
respiratori
viru
infect
primari
aim
studi
examin
pathogen
contribut
sever
ard
pulmonari
origin
children
secondari
aim
examin
profil
inflammatori
mediat
investig
prognost
factor
fatal
outcom
sever
ard
pulmonari
origin
children
use
multivari
analysi
measur
use
elisa
kit
ii
shinotest
corp
tokyo
japan
late
inflammatori
mediat
endotoxininduc
acut
lung
injuri
sampl
run
duplic
averag
concentr
use
statist
analysi
mannwhitney
u
test
use
determin
statist
signific
differ
clinic
data
cytokinechemokin
level
group
fisher
exact
test
use
bivari
analysi
categor
data
associ
cytokinechemokin
level
clinic
data
test
linear
regress
analysi
assess
good
fit
linear
regress
model
rsquar
measur
use
use
logist
regress
analysi
analyz
relationship
independ
outcom
predictor
outcom
assess
good
fit
logist
regress
model
demograph
clinic
data
summar
tabl
patient
boy
girl
rang
age
month
year
median
month
children
less
year
old
twelv
children
medic
histori
pneumonia
n
febril
convuls
n
idiopath
thrombocytopen
purpura
n
hemosiderosi
n
two
children
posit
human
immunodefici
viru
median
durat
onset
ill
picu
admiss
day
patient
admit
picu
within
day
onset
ill
median
pf
ratio
mm
hg
children
show
pf
ratio
mm
hg
peep
cm
h
day
picu
admiss
children
intub
support
mechan
ventil
pediatr
risk
mortal
prism
iii
score
assess
use
paramet
obtain
first
h
stay
picu
prism
iii
score
median
glucocorticoid
highdos
intravascular
immunoglobulin
administ
children
respect
adjunct
treatment
depend
physician
decis
tabl
fiftythre
patient
posit
either
advb
mev
cmv
addit
infect
tabl
screen
cmv
infect
possibl
caus
sever
ard
pulmonari
origin
observ
mani
immunocompet
infant
cmvassoci
pneumonia
hospit
ninetytwo
percent
cmvposit
children
coinfect
virus
cmv
infect
consid
opportunist
infect
follow
infect
anoth
viru
cmvpersist
infect
commonli
detect
bacteria
fungi
klebsiella
pneumonia
follow
acinetobact
baumannii
candida
albican
gener
consid
opportunist
nosocomi
infect
tabl
streptococcu
pneumonia
repres
pathogen
communityacquir
pneumonia
detect
two
children
measl
taken
togeth
case
sever
ard
pulmonari
origin
present
studi
develop
viral
pneumonia
rather
primari
bacteri
pneumonia
patient
bacteremia
fungemia
tabl
thirtytwo
children
die
picu
nonsurvivor
nearli
half
die
within
first
day
picu
admiss
studi
survivor
picusurvivor
discharg
picu
aliv
shown
tabl
signific
differ
accord
anoth
classif
type
cytokin
produc
helper
type
lymphocyt
predominantli
promot
cellmedi
immun
type
cytokin
produc
helper
type
lymphocyt
predominantli
support
humor
immun
antibodi
product
cytokineschemokin
produc
simultan
counteract
effect
notabl
level
ratio
ratio
nonsurvivor
significantli
higher
survivor
tabl
level
associ
fatal
outcom
influenc
mev
advb
bacteri
fungal
infect
fig
ratio
suggest
rel
balanc
type
type
cytokin
ratio
higher
nonsurvivor
indic
greater
predomin
nonsurvivor
day
picu
admiss
ratio
ratio
suggest
rel
balanc
proinflammatori
cytokin
antiinflammatori
cytokin
show
data
present
number
median
interquartil
rang
crp
avail
nonsurvivor
survivor
fisher
exact
test
employ
bivari
analysi
categor
data
mannwhitney
test
use
comparison
continu
data
two
group
p
observ
nonsurvivor
advbinfect
children
lower
level
observ
mevinfect
children
fig
addit
ratio
ratio
significantli
increas
mevinfect
children
compar
uninfect
children
fig
higher
ratio
reflect
lower
level
mevinfect
patient
fig
b
higher
ratio
reflect
higher
data
shown
lower
level
mevinfect
patient
fig
patient
bacterialfung
coinfect
exhibit
markedli
higher
level
compar
uninfect
patient
differ
level
ratio
patient
without
bacteri
fungal
infect
fig
klebsiella
pneumonia
pseudomona
aeruginosa
stenotrophomona
maltophillia
data
present
number
patient
whose
sampl
posit
microorgan
picu
stay
tabl
variabl
modifi
probabl
patient
high
serum
concentr
fatal
outcom
r
therefor
frequenc
multipl
viru
infect
studi
significantli
associ
measl
outbreak
frequent
detect
viru
genom
tlf
advb
previou
studi
report
children
die
measlesassoci
pneumonia
picu
measl
outbreak
complic
advb
type
pneumonia
picumort
associ
type
caus
pathogen
rather
inflammatori
respons
induc
host
immun
evalu
differ
serum
level
inflammatori
mediat
nonsurvivor
survivor
day
picu
admiss
examin
associ
type
infect
pathogen
found
serum
level
associ
fatal
outcom
fig
dengu
patient
rare
report
prognost
mediat
ard
report
one
independ
outcom
predictor
patient
shown
studi
particularli
children
sever
ard
pulmonari
origin
respiratori
viru
infect
found
serum
level
possibl
prognost
factor
fatal
outcom
serum
level
report
relat
poor
prognosi
ard
patient
studi
serum
level
higher
children
bacteri
fungal
coinfect
children
viral
infect
although
level
associ
fatal
outcom
serum
level
associ
fatal
outcom
also
mev
infect
adv
infect
fig
therefor
appear
suitabl
independ
prognost
factor
fatal
outcom
ratio
associ
fatal
outcom
higher
ratio
day
picu
admiss
thought
reflect
measlesspecif
inflammatori
respons
present
studi
limit
first
sampl
size
small
second
result
particularli
type
detect
viru
genom
may
affect
concurr
measl
outbreak
third
includ
data
healthi
vietnames
children
age
control
thu
could
compar
serum
level
inflammatori
mediat
healthi
children
fourth
pcrdetect
viru
necessarili
caus
pathogen
diseas
persist
adv
cmv
infect
establish
primari
infect
may
detect
healthi
children
fifth
genom
rna
virus
degrad
time
sampl
collect
primer
probe
bind
sequenc
mutat
genom
could
detect
sixth
pathogen
may
present
detect
summari
first
report
determin
profil
pathogen
involv
sever
ard
pulmonari
origin
children
respiratori
viru
infect
found
upregul
detect
day
picu
admiss
one
possibl
prognost
factor
affect
fatal
outcom
rather
type
pathogen
suggest
modul
inflammatori
respons
regardless
pathogen
type
critic
clinic
manag
patient
